<![CDATA[advisory committee and patient Resources | BNET]]> en-us <![CDATA[FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia.]]> Tue, 16 Oct 2007 00:00:00 -0700 <![CDATA[Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee]]> Tue, 11 Sep 2007 00:00:00 -0700 AMGN AMGN <![CDATA[Patients Urge Implementation of FDA Advisory Committee Recommendation for Public Health Emergency; HHS Blood Safety and Availability Advisory Committee Stresses Need for Immediate Action to Protect Patients' Lives]]> Thu, 02 Jun 2005 00:00:00 -0700 <![CDATA[U.S. Food and Drug Administration Advisory Committee Recommends New Treatment, CAMPATH, for Patients With Chronic Lymphocytic Leukemia]]> Thu, 14 Dec 2000 00:00:00 -0800 <![CDATA[Ligand's NDA for Panretin Gel Recommended for Approval by FDA Advisory Committee For Topical Treatment of AIDS-Related KS]]> Mon, 16 Nov 1998 00:00:00 -0800 <![CDATA[FDA Advisory Committee Recommends Approval of First Test to Select Potential Patients for New Biologic Drug for Breast Cancer]]> Fri, 04 Sep 1998 00:00:00 -0700 <![CDATA[FDA Advisory Committee concludes that COPAXONE is safe and effective for treatment of patients with relapsing multiple sclerosis]]> Thu, 19 Sep 1996 00:00:00 -0700